Top

Gepubliceerd in:

01-05-2014 | Original Paper

The Subjective Experience of Being Medicated in Troubled Youth: A Sample from Residential Treatment

Auteurs: Robert Foltz, Jonathan C. Huefner

Gepubliceerd in: Journal of Child and Family Studies | Uitgave 4/2014

Abstract

The use of psychotropic medications in youth has significantly increased in recent years. Moreover, the use of multiple medications, or polypharmacy, has seen a corresponding increase. The use of medications is largely based on diagnostic impressions and the targeted symptom. However, due to the dearth of applied research with severely troubled youth, there is very little “evidence base” to guide this practice. The Survey of Adolescent Treatment Experience study surveyed youth, currently placed in residential care, on their impressions of medication effectiveness on a wide-range of symptom categories. Youth report only mediocre effectiveness in their medication across a range of symptom questions. Approximately one third of youth indicated that they felt positive about taking medications. On average, slightly less than 50 % of youth reported benefits from medications across symptom categories. It is argued that these findings should inform the efforts toward individualized treatment models.

vorige artikel Psychotropic Medication Management Within Residential Treatment Centers: Physician Opinions About Difficulties and Barriers

volgende artikel A. M. Heru: Working with Families in Medical Settings: A Multidisciplinary Guide for Psychiatrists and Other Health Professionals

American Association of Children’s Residential Centers. (2000). Outcomes in children’s residential treatment centers: A national survey. Washington DC: Author.

Antonuccio, D., & Healy, D. (2012). Relabeling the medications we call antidepressants. Scientifica, 2012, 1–6. doi:10.6064/2012/965908.CrossRef

Barzman, D. H., & Findling, R. L. (2008). Pharmacological treatment of pathologic aggression in children. International Review of Psychiatry, 20, 151–157. doi:10.1080/09540260801887819.PubMedCrossRef

Bellonci, C., Griffith, A. K., Huefner, J. C., Preston, S. (2011, April). A secret strength of residential treatment centers: Reducing psychotropic medication use through multi-disciplinary assessment at Boys Town and the Walker School. Paper presented at the 55th annual conference of the American Association of Children’s Residential Centers, Seattle, WA.

Brown, R. T., Antonuccio, D., DuPaul, G. J., Fristad, M., King, C. A., Leslie, L. K., et al. (2006). Psychopharmacological, psychosocial, and combined interventions for childhood disorders: Evidence base, contextual factors, and future directions. Washington DC: American Psychological Association.

Caccavale, J., Morris, J., Casciani, J., & Reeves, J. (2010). Failure to serve: The misuse of medications as first line treatments for behavioral disorders. Garden Grove CA: National Alliance of Professional Psychology Providers.

Comer, J. S., Olfson, M., & Mojtabai, R. (2010). National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996–2007. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 1001–1010. doi:10.1016/j.jaac.2010.07.007.PubMedCentralPubMedCrossRef

Connolly, S. D., Bernstein, G. A., & Workgroup on Quality Issues. (2007). Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 267–283. doi:10.1097/01.chi.0000246070.23695.06.PubMedCrossRef

Connor, D. F., Doerfler, L. A., Toscano, P. F., Volungis, A. M., & Steingard, R. J. (2004). Characteristics of children and adolescents admitted to a residential treatment center. Journal of Child and Family Studies, 13, 497–510. doi:10.1023/B:JCFS.0000044730.66750.57.CrossRef

Connor, D. F., & McLaughlin, T. J. (2005). A naturalistic study of medication reduction in a residential treatment setting. Journal of Child and Adolescent Psychopharmacology, 15, 302–310. doi:10.1089/cap.2005.15.302.PubMedCrossRef

Connor, D. F., Ozbayrak, K. R., Harrison, R. J., & Melloni, R. H. J. (1998). Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment. Journal of Child and Adolescent Psychopharmacology, 8, 27–38. doi:10.1016/S0031-9384(96)00373-3.PubMedCrossRef

Connor, D. F., Ozbayrak, K. R., Kusiak, K. A., Caponi, A. B., & Melloni, R. H. (1997). Combined pharmacotherapy in children and adolescents in a residential treatment center. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 248–254. doi:10.1097/00004583-199702000-00016.PubMedCrossRef

Constantine, R., & Tandon, R. (2008). Changing trends in pediatric antipsychotic use in Florida’s Medicaid program. Psychiatric Services, 59, 1162–1168. doi:10.1176/appi.ps.59.10.1162.PubMedCrossRef

Cooper, W. O., Arbogast, P. G., Ding, H., Hickson, G. B., Fuchs, D. C., & Ray, W. A. (2006). Trends in prescribing of antipsychotic medications for US children. Ambulatory Pediatrics, 6, 79–83. doi:10.1016/j.ambp.2005.11.002.PubMedCrossRef

Drais-Parrillo, A. A. (2004). The odyssey project: A descriptive and prospective study of children and youth in residential group care and therapeutic foster care. Washington, DC: Child Welfare League of America.

Duffy, F. F., Narrow, W. E., Rae, D. S., West, J. C., Zarin, D. A., Rubio-Stipec, M., et al. (2005). Concomitant pharmacotherapy among youths treated in routine psychiatric practice. Journal of Child and Adolescent Psychopharmacology, 15, 12–25. doi:10.1089/cap.2005.15.12.PubMedCrossRef

Duppong Hurley, K., Trout, A., Chmelka, M. B., Burns, B. J., Epstein, M. H., Thompson, R. W., et al. (2009). The changing mental health needs of youth admitted to residential group home care: Comparing mental health status at admission in 1995 and 2004. Journal of Emotional and Behavioral Disorders, 17, 164–176. doi:10.1177/1063426608330791.CrossRef

Floersch, J. (2004). The subjective experience of youth psychotropic treatment. Social Work Mental Health, 1, 51–69.CrossRef

Floersch, J., Townsend, L., Longhofer, J., Munson, M., Winbush, V., Kranke, D., et al. (2009). Adolescent experience of psychotropic treatment. Transcultural Psychiatry, 46, 157–179. doi:10.1177/1363461509102292.PubMedCentralPubMedCrossRef

Griffith, A. K., Ingram, S. D., Barth, R. P., Trout, A. L., Duppong Hurley, K., Thompson, R. W., et al. (2009). The family characteristics of youth entering a residential care program. Residential Treatment for Children & Youth, 26, 135–150. doi:10.1080/08865710902914283.CrossRef

Griffith, A. K., Smith, G., Huefner, J. C., Epstein, M. H., Thompson, R. W., Singh, N. N., et al. (2012). Youth at entry to residential treatment: Understanding psychotropic medication use. Child and Youth Services Review, 34, 2028–2035. doi:10.1016/j.childyouth.2012.05.002.CrossRef

Handwerk, M. L., Smith, G. L., Thompson, R. W., Spellman, D. F., & Daly, D. L. (2008). Psychotropic medication utilization at a group-home residential facility for children and adolescents. Journal of Child and Adolescent Psychopharmacology, 18, 517–525. doi:10.1089/cap.2008.012.PubMedCrossRef

Heflinger, C. A., & Humphreys, K. L. (2008). Identification and treatment of children with oppositional defiant disorder: A case study of one state’s public service system. Psychological Services, 5, 139–152. doi:10.1037/1541-1559.5.2.139.CrossRef

Hogue, A., & Dauber, S. (2013). Diagnostic profiles among urban adolescents with unmet treatment needs: Comorbidity and perceived need for treatment. Journal of Emotional and Behavioral Disorders. doi:10.1177/1063426611407500.PubMedCentralPubMed

Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6, 65–70.

Hussey, D. L., Drinkard, A. M., Falletta, L., & Flannery, D. J. (2008). Understanding clinical complexity in delinquent youth: Comorbidities, service utilization, cost, and outcomes. Journal of Psychoactive Drugs, 40, 85–95.PubMedCrossRef

Hussey, D. L., & Guo, S. (2005). Forecasting length of stay in child residential treatment. Child Psychiatry and Human Development, 36, 95–111. doi:10.1007/s10578-004-3490-9.PubMedCrossRef

Jensen, P. S., Arnold, L. E., Swanson, J. M., Vitiello, B., Abikoff, H. B., Greenhill, L. L., et al. (2007). 3-year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 213–235. doi:10.1097/CHI.0b013e3180686d48.

Kowatch, R. A., Fristad, M., Birmaher, B., Wagner, K. D., Findling, R. L., Hellander, M., et al. (2005). Treatment guidelines for children and adolescents with bipolar disorder: Child psychiatric workgroup on bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 213–235. doi:10.1097/00004583-200503000-00006.PubMedCrossRef

Kranke, D., Floersch, J., Townsend, L., & Munson, M. (2010). Stigma experience among adolescents taking psychiatric medication. Children and Youth Services Review, 32, 496–505. doi:10.1016/j.childyouth.2009.11.002.CrossRef

Lee, M. Y., & Jonson-Reid, M. (2009). Needs and outcomes for low income youth in special education: Variations by emotional disturbance diagnosis and child welfare contact. Children and Youth Services Review, 31, 722–731. doi:10.1016/j.childyouth.2009.01.005.PubMedCentralPubMedCrossRef

LeFever, G. B., Arcona, A. P., & Antonuccio, D. O. (2003). ADHD among American schoolchildren evidence of over diagnosis and overuse of medication. The Scientific Review of Mental Health Practice, 2, 49–60.

Leo, J. (2006). The truth about academic medicine: Children on psychotropic drugs and the illusion of science. In S. Timimi & B. Maitra (Eds.), Critical voices in child and adolescent mental health (pp. 107–127). London: Free Association Books.

Leslie, L. K., Mackie, T., Dawson, E. H., Bellonci, C., Schoonover, B. R., Rodday, A. M., et al. (2010). Multi-state study on psychotropic medication oversight in foster care. Boston: Tufts Clinical and Translational Science Institute.

Linacre, J. M. (2008). A user’s guide to Winsteps ministep Rasch-model computer programs: Program manual 3.66.0. Chicago, IL: Author.

Longhofer, J., & Floersch, J. (2010). Desire and disappointment: Adolescent psychotropic treatment and adherence. Anthropology & Medicine, 17, 159–172. doi:10.1080/13648470.2010.493599.CrossRef

Masters, K. J., Bellonci, C., & Workgroup on Quality Issues. (2002). Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions with special reference to seclusion and restraint. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 4s–25s.PubMedCrossRef

McClellan, J., Kowatch, R., Findling, R. L., & Workgroup on Quality Issues. (2007). Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 107–125. doi:10.1097/CHI.0b013e3180691779.PubMedCrossRef

Mehler-Wex, C., Kölch, M., Kirchheiner, J., Antony, G., Fegert, J. M., & Gerlach, M. (2009). Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy. Child and Adolescent Psychiatry and Mental Health, 3, 1–9. doi:10.1186/1753-2000-3-14.CrossRef

Mojtabai, R., & Olfson, M. (2010). National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry, 67, 26–36. doi:10.1001/archgenpsychiatry.2009.175.PubMedCrossRef

Molina, B. S., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., et al. (2009). The MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 484–500. doi:10.1097/CHI.0b013e31819c23d0.PubMedCentralPubMedCrossRef

Munson, M. R., Narendorf, S. C., & McMillen, J. C. (2011). Knowledge of and attitudes towards behavioral health services among older youth in the foster care system. Child and Adolescent Social Work Journal, 28, 97–112. doi:10.1007/s10560-010-0223-8.CrossRef

Najjar, F., Welch, C., Grapentine, W. L., Sachs, H., Siniscalchi, J., & Price, L. H. (2004). Trends in psychotropic drug use in a child psychiatric hospital from 1991–1998. Journal of Child and Adolescent Psychopharmacology, 14, 87–93. doi:10.1089/104454604773840526.PubMedCrossRef

Nevels, R. M., Dehon, E. E., Alexander, K., & Gontkovsky, S. T. (2010). Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: A review of current and potentially promising treatment options. Experimental and Clinical Psychopharmacology, 18, 184–201. doi:10.1037/a0018059.PubMedCrossRef

Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry, 63, 679–685.PubMedCrossRef

Olfson, M., Crystal, S., Huang, C., & Gerhard, T. (2010). Trends in antipsychotic drug use by very young, privately insured children. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 13–23. doi:10.1097/00004583-201001000-00005.PubMed

Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 514–521. doi:10.1097/00004583-200205000-00008.PubMedCrossRef

Pappadopulos, E., Rosato, N. S., Correll, C. U., Findling, R. L., Crystal, S., & Jensen, P. S. (2011). Experts’ recommendations for treating maladaptive aggression in youth. Journal of Child and Adolescent Psychopharmacology, 21, 505–515. doi:10.1089/cap.2010.0128.PubMedCentralPubMedCrossRef

Pliszka, S., & Workgroup on Quality Issues. (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 894–921. doi:10.1097/chi.0b013e318054e724.PubMedCrossRef

Pottick, K. J., Warner, L. A., & Yoder, K. A. (2005). Youths living away from families in the US mental health system: Opportunities for targeted intervention. Journal of Behavioral Health Services & Research, 32, 264–281. doi:10.1007/BF02291827.CrossRef

Pumariega, A. J., Atkins, D. L., Rogers, K., Montgomery, L., Nybro, C., Caesar, R., et al. (1999). Mental health and incarcerated youth. II: Service utilization. Journal of Child and Family Studies, 8, 205–215. doi:10.1023/A:1022092002435.CrossRef

Rubin, D., Matone, M., Huang, Y. S., dosReis, S., Feudtner, C., & Localio, R. (2012). Interstate variation in trends of psychotropic medication use among Medicaid-enrolled children in foster care. Children and Youth Services Review, 34, 1492–1499. doi:10.1016/j.childyouth.2012.04.006.CrossRef

Shaffer, D., Fisher, P., Dulcan, M. K., Davies, M., Piacentini, J. C., Schwab-Stone, M. E., et al. (1996). The NIMH diagnostic interview schedule for children version 2.3 (DISC-2.3): Description, acceptability, prevalence rates, and performance in the MECA study. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 865–877.PubMedCrossRef

Singh, M. K., & Chang, K. D. (2012). The neural effects of psychotropic medications in children and adolescents. Child and Adolescent Psychiatric Clinics of North America, 21, 753–771. doi:10.1016/j.chc.2012.07.010.PubMedCentralPubMedCrossRef

Substance Abuse and Mental Health Services Administration. (2007). Results from the 2006 national survey on drug use and health: National findings (SMA 07-4293). Washington, DC: Office of Applied Studies.

Substance Abuse and Mental Health Services Administration. (2008). Out-of-home services for emotional or behavioral problems among youths aged 12–17: 2002–2006. Rockville, MD: Office of Applied Studies.

Taylor, D. (2010). Antipsychotic polypharmacy—confusion reigns. The Psychiatrist, 34, 41–43.CrossRef

Townsend, L., Floersch, J., & Findling, R. L. (2009). Adolescent attitudes toward psychiatric medication: The utility of the drug attitude inventory. Journal of Child Psychology and Psychiatry, 50, 1523–1531. doi:10.1111/j.1469-7610.2009.02113.x.PubMedCentralPubMedCrossRef

Treatment for Adolescents with Depression Study (TADS) Team. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled trial. Journal of the American Medical Association, 292, 807–820.CrossRef

Treatment for Adolescents with Depression Study (TADS) Team. (2009). The treatment for adolescents with depression study (TADS): Outcomes over 1 year of naturalistic follow-up. The American Journal of Psychiatry, 166, 1141–1149. doi:10.1176/appi.ajp.2009.08111620.CrossRef

Wagner, K. D., Redden, L., Kowatch, R. A., Wilens, T. E., Segal, S., Chang, K., et al. (2009). A double-blind, randomized, placebo-controlled trial of Divalproex extended-release in the treatment of bipolar disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 519–532. doi:10.1097/CHI.0b013e31819c55ec.PubMedCrossRef

Woolston, J. L. (1999). Combined pharmacotherapy: Pitfalls of treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1455–1457. doi:10.1097/00004583-199911000-00021.PubMedCrossRef

Zito, J. M., Craig, T. J., & Wanderling, J. (1994). Pharmacoepidemiology of 330 child/adolescent psychiatric patients. Journal of Pharmacoepidemiology, 3, 47–62. doi:10.1300/J055V03N01_04.CrossRef

Zito, J. M., Derivan, A. T., Kratochvil, C. J., Safer, D. J., Fegert, J. M., & Greenhill, L. L. (2008). Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring. Child and Adolescent Psychiatry and Mental Health, 2, 24. doi:10.1186/1753-2000-2-24.

Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., et al. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatrics and Adolescent Medicine, 157, 17–25. doi:10.1001/archpedi.157.1.17.PubMedCrossRef

Titel: The Subjective Experience of Being Medicated in Troubled Youth: A Sample from Residential Treatment
Auteurs: Robert Foltz
Jonathan C. Huefner
Publicatiedatum: 01-05-2014
Uitgeverij: Springer US
Gepubliceerd in: Journal of Child and Family Studies / Uitgave 4/2014
Print ISSN: 1062-1024
Elektronisch ISSN: 1573-2843
DOI: https://doi.org/10.1007/s10826-013-9842-y

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 4/2014

Medically Defining, Screening, and Treating Conduct Disorder: A French Controversy

A Model of Pediatric Psychopharmacology-Psychotherapy Treatment Integration in the Ambulatory Clinical Setting

Trends in Psychotropic Medication Use for Medicaid-Enrolled Preschool Children

Psychotropic Medication Use with Troubled Children and Youth

Psychotropic Medication Management Within Residential Treatment Centers: Physician Opinions About Difficulties and Barriers

Service and Medication Use and Their Effects on Arrest Rates Among Children with Emotional Disturbances Before Disenrollment from Medicaid